Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin versus placebo for fasting hypoglycemia risk in type 2 diabetes on insulin glargine and metformin
2016-004480-39Phase 2Completed
- Sponsor
- Profil
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Profil. Primary endpoint: Number of chemical hypoglycemic episodes. Started Nov 2017; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-004480-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004480-39.